223 related articles for article (PubMed ID: 19049372)
21. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.
Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P
Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806
[TBL] [Abstract][Full Text] [Related]
22. [Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients].
Buczkowska EO; Dworzecki T; Wiedermann G; Malanowicz B; Szot D
Przegl Lek; 2005; 62(1):49-53. PubMed ID: 16053222
[TBL] [Abstract][Full Text] [Related]
23. Reassessment of external insulin infusion pumps.
Hotta SS; Adams D
Health Technol Assess Rep; 1990; (9):1-9. PubMed ID: 2129578
[TBL] [Abstract][Full Text] [Related]
24. Bolus Calculator Safety Mandates a Need for Standards.
Walsh J; Freckmann G; Roberts R; Heinemann L
J Diabetes Sci Technol; 2017 Jan; 11(1):3-6. PubMed ID: 28264178
[No Abstract] [Full Text] [Related]
25. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes.
Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F
Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379
[TBL] [Abstract][Full Text] [Related]
26. Insulin pump therapy: guidelines for successful outcomes.
Scheiner G; Sobel RJ; Smith DE; Pick AJ; Kruger D; King J; Green K
Diabetes Educ; 2009; 35 Suppl 2():29S-41S; quiz 28S, 42S-43S. PubMed ID: 19318690
[TBL] [Abstract][Full Text] [Related]
27. [Guidelines concerning insulin dosage in children and adolescents with type 1 diabetes on continuous subcutaneous insulin infusion].
Szypowska A; Pańkowska E; Lipka M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):45-50. PubMed ID: 16704861
[TBL] [Abstract][Full Text] [Related]
28. Benefit of supplementary fat plus protein counting as compared with conventional carbohydrate counting for insulin bolus calculation in children with pump therapy.
Kordonouri O; Hartmann R; Remus K; Bläsig S; Sadeghian E; Danne T
Pediatr Diabetes; 2012 Nov; 13(7):540-4. PubMed ID: 22765260
[TBL] [Abstract][Full Text] [Related]
29. Practical pearls in insulin pump therapy.
Hirsch IB
Diabetes Technol Ther; 2010 Jun; 12 Suppl 1():S23-7. PubMed ID: 20515302
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneous insulin substitution in insulin-dependent diabetes mellitus. Pharmacokinetic and pharmacodynamic studies.
Olsson PO
Acta Med Scand Suppl; 1987; 718():1-78. PubMed ID: 3321929
[TBL] [Abstract][Full Text] [Related]
31. Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes.
Mathiesen JM; Secher AL; Ringholm L; Nørgaard K; Hommel E; Andersen HU; Damm P; Mathiesen ER
J Matern Fetal Neonatal Med; 2014 May; 27(7):724-8. PubMed ID: 23981186
[TBL] [Abstract][Full Text] [Related]
32. Fulfilling the promise of insulin pump therapy in childhood diabetes.
Tamborlane WV
Pediatr Diabetes; 2006 Aug; 7 Suppl 4():4-10. PubMed ID: 16774611
[TBL] [Abstract][Full Text] [Related]
33. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
34. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
35. An Adaptive Nonlinear Basal-Bolus Calculator for Patients With Type 1 Diabetes.
Boiroux D; Aradóttir TB; Nørgaard K; Poulsen NK; Madsen H; Jørgensen JB
J Diabetes Sci Technol; 2017 Jan; 11(1):29-36. PubMed ID: 27613658
[TBL] [Abstract][Full Text] [Related]
36. Comparison of Insulin Pump Bolus Calculators Reveals Wide Variation in Dose Recommendations.
Buchanan J; Zabinsky JA; Ferrara-Cook C; Adi S; Wong JC
J Diabetes Sci Technol; 2021 Nov; 15(6):1290-1296. PubMed ID: 32869656
[TBL] [Abstract][Full Text] [Related]
37. [Continuous subcutaneous insulin infusion with portable pumps].
Radermecker RP; Hermans MP; Legrand DA; Scheen AJ
Rev Med Liege; 2005; 60(5-6):329-34. PubMed ID: 16035289
[TBL] [Abstract][Full Text] [Related]
38. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
39. [Assessment of metabolic control and safety of continuous subcutaneous insulin infusion in prepubertal children with type 1 diabetes mellitus].
Minkina-Pedras M; Jarosz-Chobot P; Małecka-Tendera E; Deja G
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2005; 11(3):171-6. PubMed ID: 16232370
[TBL] [Abstract][Full Text] [Related]
40. Accuracy assessment of bolus and basal rate delivery of different insulin pump systems used in insulin pump therapy of children and adolescents.
Ziegler R; Waldenmaier D; Kamecke U; Mende J; Haug C; Freckmann G
Pediatr Diabetes; 2020 Jun; 21(4):649-656. PubMed ID: 32003490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
